THE ECONOMIC IMPACT OF LINEZOLID FOR THE MANAGEMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN THE CHILEAN PREVISIONAL HEALTH INSTITUTIONS (ISAPRE)

被引：0

作者：

Mould-Quevedo, J. F. ^{[1
]}

Vargas Zea, N. ^{[2
]}

Diaz-Sotelo, O. D. ^{[3
]}

Villamil Munevar, V. ^{[3
]}

Ortiz, Vecino A. ^{[4
]}

机构：

[1] Pfizer Inc, New York, NY USA

[2] Pfizer SAS, Bogota, Colombia

[3] RANDOM Fdn, Bogota, DC, Colombia

[4] Johns Hopkins Univ, Baltimore, MD USA

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 03期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A84 / A84

页数：1

共 50 条

[1] LINEZOLID FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) - A COST-EFFECTIVENESS ANALYSIS FOR THE CHILEAN NATIONAL FUND OF HEALTH
Mould-Quevedo, J. F.
Vargas Zea, N.
Diaz-Sotelo, O. D.
Villamil Munevar, V.
Ortiz, Vecino A.
VALUE IN HEALTH, 2013, 16 (03) : A88 - A89
[2] COST-EFFECTIVENESS OF LINEZOLID IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN CHILE - PRIVATE SCENARIO
Mould-Quevedo, J. F.
Vargas Zea, N.
Diaz-Sotelo, O. D.
Villamil Munevar, V.
Ortiz, Vecino A.
VALUE IN HEALTH, 2013, 16 (03) : A88 - A88
[3] COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) FOR INPATIENT AND OUTPATIENT TREATMENT SETTINGS
Stephens, J. M.
Treur, M. J.
Heeg, B. M. S.
Haider, S.
Nathwani, D.
Tice, A.
VALUE IN HEALTH, 2008, 11 (06) : A441 - A441
[4] BUDGET IMPACT ANALYSIS OF LINEZOLID IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN COLOMBIA
Diaz-Sotelo, O. D.
Barbosa Castro, T.
Ortiz, Vecino A.
Vargas Zea, N.
Quevedo, Mould J. F.
Prieto Martinez, V
VALUE IN HEALTH, 2013, 16 (03) : A84 - A84
[5] Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI)
So W.
Kuti J.L.
Nicolau D.P.
Infectious Diseases and Therapy, 2014, 3 (2) : 269 - 279
[6] Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
Weigelt, J
Itani, K
Stevens, D
Lau, W
Dryden, M
Knirsch, C
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2260 - 2266
[7] Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections
McKinnon, Peggy S.
Sorensen, Sonja V.
Liu, Larry Z.
Itani, Karnal M. F.
ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1017 - 1023
[8] Linezolid in the treatment of HIV-infected patients with complicated skin and soft tissue infections
N Khachatryan
I Dizengof
G Smirnov
Critical Care, 11 (Suppl 2):
[9] Linezolid versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
Barry J. Hartman
Current Infectious Disease Reports, 2001, 3 (5) : 448 - 449
[10] Linezolid versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
Barry J. Hartman
Current Infectious Disease Reports, 2007, 3 (5) : 448 - 449

← 1 2 3 4 5 →